Philip Morris International has delivered a strong 129.5% return over the past 5 years, yet the stock now sits in an interesting spot where the Discounted Cash Flow (DCF) intrinsic value estimate points to meaningful upside while the broader valuation checks suggest it is not an obvious bargain.

• Over 5 years, Philip Morris International has returned 129.5%, which puts recent gains front and center when judging how much value is left in the share price.
• The expanded US$1.2b investment in ZYN nicotine pouch production, alongside modified risk authorization, may support long term cash flow prospects, while rising competition from British American Tobacco's Velo pouches could pressure growth expectations and pricing power.
• The stock screens as undervalued on a Discounted Cash Flow (DCF) basis by around 17.9%, yet the broader checks give it a low value score, with only 2 out of 6 tests suggesting it is cheap.

The issue now is whether Philip Morris International's current price already reflects the ZYN growth story or if the intrinsic value estimate still offers a reasonable margin of safety.

Is Philip Morris International Still Cheap on Cash Flow?

The Discounted Cash Flow (DCF) model uses cash flow projections to estimate what Philip Morris International could be worth today. For Philip Morris International, the model starts with latest twelve month free cash flow of about $12.7b and assumes cash flows grow over time rather than shrink, which suits a mature business that is still investing in new products like ZYN.

On these assumptions, the DCF points to an intrinsic value of about $227 per share. That implies the stock is around 17.9% undervalued compared with the current price. Philip Morris International’s expanded US$1.2b ZYN investment and the FDA’s modified risk authorization help explain why the cash flow outlook used in the model remains supportive even with rising competition in nicotine pouches.

On this DCF view, Philip Morris International appears undervalued relative to the cash flows the business is projected to generate.

Our Discounted Cash Flow (DCF) analysis suggests Philip Morris International is undervalued by 17.9%. Track this in your watchlist or portfolio, or discover 51 more high quality undervalued stocks.

Is Philip Morris International Fairly Priced on Earnings?

The P/E ratio is a useful way to compare what you pay for each dollar of Philip Morris International earnings against other tobacco stocks. Right now the stock trades on about 26.7x earnings, which is well above the Tobacco industry average of about 12.2x and also above the broader peer group average of 18.7x.

The fair P/E ratio for Philip Morris International is estimated at about 27.3x, which is very close to where the stock currently trades. That suggests the market multiple already builds in the company’s profile, including its size, profitability and risks around the shift toward products such as ZYN nicotine pouches, rather than offering a clear discount or premium.

On this P/E view, Philip Morris International appears to be priced at roughly fair value compared with what the model suggests investors might typically pay for its earnings profile.

The Philip Morris International Narrative: What Would Justify Today's Price?

Simply Wall St Narratives pick up where the valuation checks on Philip Morris International leave off and spell out what would need to happen with future growth, margins and earnings for the stock to be worth materially more or less than today’s price, all on the Community page. Each one treats Philip Morris International's fair value as a thesis you can revisit over time rather than a one off snapshot of the business.

Community narratives on Philip Morris International sit quite far apart, which gives you two very different lenses on the same stock.

Bull case: roughly fairly valued

"The accelerating global adoption of smoke-free alternatives driven by increasing health awareness and regulatory moves away from combustibles is fueling strong double-digit volume and margin growth in PMI's IQOS, ZYN, and VEEV platforms..."

Bear case: 6% overvalued

"The regulatory environment is growing increasingly complex and adverse, with new or heightened restrictions and taxation frameworks on both combustible and smoke-free products posing material risks to compliance costs and future operating margins..."

Do you think there's more to the story for Philip Morris International? Head over to our Community to see what others are saying!

The Bottom Line

For Philip Morris International, the Discounted Cash Flow (DCF) estimate points to meaningful upside, while the market multiple suggests the stock already trades close to what investors typically pay for its earnings profile. That split comes from cash flow models leaning on long term funding and reinvestment into products like ZYN, while the P/E view reflects current sentiment and what peers trade on today.

The broader checks still look weak, so the valuation case rests on whether future cash flows from smoke free products justify trusting the intrinsic value estimate over the more cautious market pricing. The key question is how durable those product economics prove from here.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.